GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Center Laboratories 4123.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

28.40

+0.71%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Center Laboratories

Its shares trade on Taipei Exchange under the ticker 4123.TWO. It has been listed since 18 December 2002. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.52bn and net income of TWD 9.32bn. At that date it held total assets of TWD 34.63bn and shareholders' equity of TWD 26.49bn.

Center Laboratories, Inc. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2002-12-18. The firm's main products include dairy products and probiotic products. The firm is also involved in the manufacture, wholesale and retail of western medicines. The firm distributes its products in the domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
18 Dec 2002

Leadership

Pay as last reported

  • Ms. Su-Chi WangChairman of the Board, Chief Operating Officer, Chief Investment Officer, since 2000
  • Ms. An-Ni MaoManager of Finance & Accounting
  • Mr. Jui-Pao HsuGeneral ManagerTWD 2.6m
  • Ms. Chiun-Yu LinPlant Manager
  • Qingyu TangCorporate Governance Officer
  • Mr. Po-Chih ChangDirector
  • Mr. Chun-Hung ChenDirector
  • Ms. Chia-Ling LinDirector
  • Mr. Chang-Hai TsaiDirector
  • Ms. Pei-Chen TsaiDirector
  • Ms. Mei-Yueh HoIndependent Director
  • Mr. Shih-Chinn HoIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Center Laboratories Inc manufactures dairy and probiotic products in Taipei City.
  • The company distributes pharmaceutical products domestically and internationally.
  • Center Laboratories Inc has been listed on the stock market since 2002.

Weaknesses

  • Center Laboratories Inc focuses on dairy and probiotic products only.
  • The company's main market is limited to Taipei City and domestic Taiwan.
  • Center Laboratories Inc does not have a significant overseas presence.

Opportunities

  • Center Laboratories Inc can expand into the global pharmaceutical market.
  • The company can leverage its probiotic product line for international growth.
  • Center Laboratories Inc can increase its market share in the Health Care sector.

Threats

  • Center Laboratories Inc faces competition from other pharmaceutical companies in Taiwan.
  • The company's reliance on domestic market sales poses a risk.
  • Center Laboratories Inc must comply with international pharmaceutical regulations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.